Biocides Stakeholders' Day
The European Chemicals Agency organised its second Biocides Stakeholders' Day on Wednesday 24 September 2014 in Helsinki.
The Stakeholders' Day provided key biocides stakeholders with information about the Biocidal Products Regulation (BPR) including the tools and support available for companies. The objective of the event was to ensure that companies are aware of their roles and obligations to assist them in meeting the relevant BPR requirements.
You can follow event related discussions on twitter @EU_ECHA using the hashtag #BiocidesDay.
For any event related enquiries, you can contact us at: echa-events (at) echa.europa.eu
If you participated either in person or via web-streaming, please share your views with us so that we can further improve the event in the future. You can give your feedback through a short questionnaire.
Presentations & recording
Note: in order to view the recordings of all plenary sessions, click on the link below and scroll to the bottom of the page.
SESSION 1 – The EU biocidal market one year after entry into operation
Opening - Geert DANCET, Executive Director, ECHA
Achievements - Hugues KENIGSWALD, Biocides Assessment Unit, ECHA
Forthcoming revision of the fee regulation and National fees, relevant policy Issues - Pierre CHORAINE, DG Environment, European Commission
BPR: opportunities and challenges for biocidal product formulators in 2014 - Sylvie LEMOINE, A.I.S.E.
SESSION 2 – Legislative development and support for applicants
BPR amendment and secondary legislation - Camilla BUCHANAN, Legal Affairs Unit, ECHA
New review programme Regulation - Erik VAN DE PLASSCHE, Chair of the Biocidal Products Committee, ECHA
IT tools - Jan WEBER, Biocides Assessment Unit, ECHA
Support for applicants - Valerio SPINOSI, Biocides Assessment Unit, ECHA
SESSION 3 – New opportunities and challenges
Article 95 - Hugues KENIGSWALD, Biocides Assessment Unit, ECHA
Data sharing - Jonathan KÜSTER, Substance Identity and Data Sharing Unit, ECHA
Union authorisation: analysis of benefits and risks - industry perspective - Ludger GRUNWALD, Ecolab
Biocidal product family - work in progress - Camelia MIHAI, Cefic